Acorah Software Products - Accounts Production 16.0.110 false true false true No description of principal activity 28 July 2023 31 July 2024 31 July 2024 15034340 Dr Marco Spartera Dr Anna Lena Schaupp iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15034340 2023-07-27 15034340 2024-07-31 15034340 2023-07-28 2024-07-31 15034340 frs-core:CurrentFinancialInstruments 2024-07-31 15034340 frs-bus:PrivateLimitedCompanyLtd 2023-07-28 2024-07-31 15034340 frs-bus:FilletedAccounts 2023-07-28 2024-07-31 15034340 frs-bus:Micro-entities 2023-07-28 2024-07-31 15034340 frs-bus:AuditExempt-NoAccountantsReport 2023-07-28 2024-07-31 15034340 frs-bus:Director1 2023-07-28 2024-07-31 15034340 frs-bus:Director1 2023-07-27 15034340 frs-bus:Director1 2024-07-31 15034340 frs-bus:Director2 2023-07-28 2024-07-31
Registered number: 15034340
Oxford Cardiovascular Health Ltd
Unaudited Financial Statements
For the Period 28 July 2023 to 31 July 2024
TaxAssist Accountants
Balance Sheet
Registered number: 15034340
31 July 2024
£
Fixed assets 100
Current assets 77,856
Prepayments and accrued income 7,430
Creditors: Amounts Falling Due Within One Year (19,009 )
NET CURRENT ASSETS 66,277
TOTAL ASSETS LESS CURRENT LIABILITIES 66,377
Accruals and deferred income (1,481 )
NET ASSETS 64,896
CAPITAL AND RESERVES 64,896

Notes

1. General Information
Oxford Cardiovascular Health Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15034340 . The registered office is 265 Cowley Road, Oxford, OX4 1XQ.
2. Average Number of Employees
Average number of employees, including directors, during the year was  2
2
3. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 28 July 2023 Amounts advanced Amounts repaid Amounts written off As at 31 July 2024
£ £ £ £ £
Dr Marco Spartera - 32,032 - - 32,032
The above loan is unsecured, interest is charged at 2.25% and it is repayable on demand.
Page 0
Page 1
For the period ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Marco Spartera
Director
06/01/2025